Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of attempting suicide. Stimulants, such as methylphenidate hydrochloride, are the most common treatment for ADHD, but the association between their therapeutic use and suicide is unclear.
Association of Risk of Suicide Attempts With Methylphenidate Treatment
CARUCCI, SARA;ZUDDAS, ALESSANDRO;
2017-01-01
Abstract
Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of attempting suicide. Stimulants, such as methylphenidate hydrochloride, are the most common treatment for ADHD, but the association between their therapeutic use and suicide is unclear.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
jamapsychiatry Man 2017 mph:suicide.pdf
Solo gestori archivio
Tipologia:
versione editoriale (VoR)
Dimensione
277.17 kB
Formato
Adobe PDF
|
277.17 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I metadati presenti in IRIS UNICA sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono protetti da diritto d'autore, salvo diversa indicazione.
